Download presentation
Presentation is loading. Please wait.
Published byAlannah Lynch Modified over 9 years ago
1
Subarachnoid Hemorrhage in Type 1 Diabetes A prospective cohort study of 4,083 patients with diabetes Featured Article: Miikka Korja, M.D., P.H.D., Lena M. Thorn, M.D., P.H.D., Stefanie Hägg, M.B., Jukka Putaala, M.D., P.H.D., Ron Liebkind, M.D., P.H.D., Valma Harjutsalo, P.H.D., Carol M. Forsblom, P.H.D., Daniel Gordin, M.D., P.H.D., Turgut Tatlisumak, M.D., P.H.D., Per-Henrik Groop, M.D., P.H.D., On Behalf of The FinnDiane Study Group* Diabetes Care Volume 36: 3754-3758 November, 2013
2
STUDY OBJECTIVE To estimate the incidence of subarachnoid hemorrhage (SAH) in type 1 diabetes Korja M. et al. Diabetes Care 2013;36:3754-3758
3
STUDY DESIGN AND METHODS Incidence of first-ever SAH events was analyzed using the nationwide Finnish Diabetic Nephropathy (FinnDiane) Study cohort Korja M. et al. Diabetes Care 2013;36:3754-3758
4
RESULTS During the follow-up time of 36,680 person-years, 15 patients experienced an aneurysmal or nonaneurysmal SAH Thus, the crude incidence of SAH was 40.9 per 100,000 person-years One patient had a verified aneurysmal SAH Four patients died suddenly of an SAH, which was most likely caused by an aneurysm Korja M. et al. Diabetes Care 2013;36:3754-3758
5
RESULTS SAHs in 10 of 15 patients were classified as nonaneurysmal SAH Thus, the crude incidence of nonaneurysmal SAH was 27.3 per 100,000 person-years None of the nonaneurysmal SAHs were fatal Korja M. et al. Diabetes Care 2013;36:3754-3758
6
CONCLUSIONS Incidence of nonaneurysmal SAH is high among patients with type 1 diabetes Nonaneurysmal SAH is a distinct new microvascular complication in type 1 diabetes Korja M. et al. Diabetes Care 2013;36:3754-3758
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.